Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7133 results

Janssen submits NDA for Yondelis in soft tissue sarcoma

Janssen submits NDA for Yondelis in soft tissue sarcoma

25-11-2014

US health care giant Johnson & Johnson’s subsidiary Janssen Research & Development has submitted a…

Janssen Research and DevelopmentOncologyPharmaceuticalRegulationUSAYondelis

Predictive biomarkers could help costly cancer drugs secure market access

25-11-2014

Biomarker driven prescribing is likely to positively influence perceptions of oncology drugs for both…

EuropeMarkets & MarketingOncologyPharmaceuticalPricing

AstraZeneca plans further Russian expansion

25-11-2014

Anglo-Swedish pharma major AstraZeneca plans to continue active development on the Russian pharmaceutical…

AstraZenecaFinancialPharmaceuticalProductionRussia

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

25-11-2014

The global acute myeloid leukemia therapeutics market is predicted to increase from $632.6 million in…

GlobalMarkets & MarketingmidostaurinOncologyPharmaceuticalquizartinib

Russian government predicts bright prospects to national pharma industry

Russian government predicts bright prospects to national pharma industry

25-11-2014

The Russian pharmaceutical industry is booming, despite the economic recession in the country and devaluation…

Markets & MarketingPharmaceuticalPricingRegulationRussia

HIV therapy Rezolsta approved by EC

HIV therapy Rezolsta approved by EC

25-11-2014

Belgium-based Janssen-Cilag International NV, a subsidiary of US health care giant Johnson & Johnson,…

Anti-viralsEuropeJanssen-CilagPharmaceuticalPrezistaRegulation

Novartis' Signifor approved in EU for acromegaly patients

Novartis' Signifor approved in EU for acromegaly patients

25-11-2014

The European Commission has approved Swiss drug major Novartis’ Signifor (pasireotide) for patients…

NovartisPharmaceuticalRare diseasesRegulationSigniforSwitzerland

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

25-11-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaDuaklir GenuairPharmaceuticalRegulationRespiratory and PulmonaryUK

US FDA pushes back decision date for Novartis’ panobinostat

US FDA pushes back decision date for Novartis’ panobinostat

25-11-2014

The US Food and Drug Administration has extended its priority review period by up to three months for…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

BioMarin to acquire Prosensa for up to $840 million

BioMarin to acquire Prosensa for up to $840 million

24-11-2014

US drugmaker BioMarin Pharmaceutical has entered into a definitive agreement to purchase all of the outstanding…

BioMarin PharmaceuticaldrisapersenMergers & AcquisitionsPharmaceuticalProsensaRare diseases

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

24-11-2014

Pharma, biotech and health care companies convened in London last week to update investors at the Jefferies…

FinancialHealth Medical PharmaPharmaceuticalRocheUK

Meaningful discussions at 9th International Summit of Heads of Medicines Regulatory Agencies

24-11-2014

Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegates of Canada,…

BrazilCanadaChinaPharmaceuticalProductionRegulation

MRC Technology and China’s Yabao Pharma partner to develop Parkinson’s drugs

24-11-2014

The UK’s independent medical research charity MRC Technology and Chinese drugmaker Yabao Pharmaceutical…

ChinaLicensingMRC TechnologyNeurologicalPharmaceuticalResearchTaiwanYabao Pharmaceutical

Unexpected resignation of Lundbeck’s CEO

24-11-2014

Danish CNS specialist Lundbeck this morning announced the resignation of its chief executive, Ulf Wiinberg,…

BoardroomManagementPharmaceutical

EMA unit backs new hep C drugs Exviera and Viekirax from AbbVie

EMA unit backs new hep C drugs Exviera and Viekirax from AbbVie

21-11-2014

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

AbbVieAnti-viralsEuropeExvieraPharmaceuticalRegulationViekirax

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

21-11-2014

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued…

CerdelgaEuropeGenzymePharmaceuticalRegulationSanofi

CHMP positive opinion on Victoza in type 2 diabetes patients with moderate renal impairment

CHMP positive opinion on Victoza in type 2 diabetes patients with moderate renal impairment

21-11-2014

The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive…

DiabetesEuropeNovo NordiskPharmaceuticalRegulationVictoza

EMA makes recommendation for reducing heart attack risk of Servier's Corlentor/Procoralan

EMA makes recommendation for reducing heart attack risk of Servier's Corlentor/Procoralan

21-11-2014

The European Medicines Agency has reviewed angina medication Corlentor/Procoralan (ivibradine), manufactured…

Cardio-vascularEuropePharmaceuticalProcoralanRegulationServier

Takeda US president quits

21-11-2014

The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole,…

BoardroomManagementPharmaceuticalTakeda PharmaceuticalUSA

Highlights from the Jefferies 2014 Global Healthcare Conference

Highlights from the Jefferies 2014 Global Healthcare Conference

21-11-2014

Pharma, biotech and health care companies convened in London this week to update investors at the Jefferies…

ALK AbelloClinigen GroupCubistFinancialGW PharmaceuticalsPeter GeorgePharmaceuticalUK

France negotiates lowest price in Europe for Gilead’s Sovaldi

France negotiates lowest price in Europe for Gilead’s Sovaldi

21-11-2014

The discount negotiated by the French government on hepatitis C drug Sovaldi (sofosbuvir), produced by…

FranceGilead SciencesNephrology and HepatologyPharmaceuticalPoliticsPricingRegulationSovaldi

1 to 25 of 7133 results

Back to top